Cadila has launched generic Pramipexole tablets, used for treating Parkinson's disease, in the American market.The company's subsidiary Zydus Cadila has launched the Pramipexole tablets in the strengths of of 0.125 mg, 0.25 mg, 0.5 mg, 1 mg and 1.5 mg.
The sale of Pramipexole tablets in 2010 is estimated to be USD 632 million according to healthcare information solutions company NDC Health. Pramipexole's patent, which has expired, was held by German drugmaker Boehringer Ingelheim. Parkinson''s disease is a progressive disorder marked by muscle rigidity, weakness, shaking, tremor, and eventually difficulty in walking and talking.
crackcrack
